JPRN-UMIN000039682Not yet recruiting未知
Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response - Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Hiroshima University
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 50years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1, The person with regular hospital visit 2, THe person who have a axiuos about thier health. 3, The person with weight less than 40kg. 4, the person who did blood donation within 1 month. 5, The person possibly be pregnant. 6, The person has a history of infectious disease within a week. 7, The person who has a direct interst with the investigators, like teacher and student. 8, The person who is recognized as inappropriate for the candidate by investigators.
Investigators
Similar Trials
Recruiting
Phase 1
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid TumorsNonsmall Cell Lung CancerSolid Tumor, AdultNCT03778814Second Affiliated Hospital of Guangzhou Medical University30
Not yet recruiting
Not Applicable
Induction of neo*antigen specific cytotoxic T cells by autologous tumor lysate-loaded specialized cross*presenting dendritic cells in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy, the NEODOC studyhigh grade serous ovarian cancer10038594ovarian cancerepithelial ovarian cancerNL-OMON54480Radboud Universitair Medisch Centrum10
Recruiting
Not Applicable
Adoptive therapy with TCR gene-engineered T cells to treat patients with MAGE-C2-positive melanoma and head and neck cancer.head and neck squamous cell carcinomamaligne melanomauveal melanoma100300541002765610040900skin cancerNL-OMON52657Erasmus MC, Universitair Medisch Centrum Rotterdam20
Recruiting
Phase 2
MAGE-C2 TCR T cell therapy2024-516922-70-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)20
Terminated
Phase 2
Analyzing Childhood Recall Antigens in Patients With Pancreatic CancerPancreatic CancerNCT03848182Albert Einstein College of Medicine10